Viagra’s Second Wind: Pfizer Revatio Approved For Pulmonary Hypertension
Executive Summary
Pfizer's post-marketing commitments for Revatio include submitting a plan to educate health care providers that the pulmonary arterial hypertension therapy has the same active ingredient as the erectile dysfunction drug Viagra
You may also be interested in...
FDA Endpoint Development For Pediatric Pulmonary Arterial Hypertension Focuses On Pfizer's Revatio
The standard exercise test is a problem for many pediatric patients, and FDA's Cardiovascular and Renal Drugs Advisory Committee will assess alternatives.
Lilly Brings Full Value Of Cialis In-House With Purchase Of Partner ICOS
Lilly will acquire its joint venture partner ICOS for approximately $2.1 bil. to gain the full rights to the erectile dysfunction drug Cialis (tadalafil), which the two companies have partnered on since 1998
Lilly Brings Full Value Of Cialis In-House With Purchase Of Partner ICOS
Lilly will acquire its joint venture partner ICOS for approximately $2.1 bil. to gain the full rights to the erectile dysfunction drug Cialis (tadalafil), which the two companies have partnered on since 1998